Compounds > nocodazole

nocodazole and bi 2536

nocodazole has been researched along with bi 2536 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Foley, EA; Kapoor, TM; Maldonado, M1
Biankin, AV; Caldon, CE; Clark, SJ; Cowley, MJ; Gallego-Ortega, D; Gee, JM; McCloy, RA; Musgrove, EA; Nicholson, RI; Ormandy, CJ; Print, CG; Sergio, CM; Stone, A; Valdes-Mora, F1
Cassimeris, L; Silva, VC1
Ahmad, N; Bi, P; Burcham, G; Elzey, BD; Konieczny, SF; Kuang, S; Li, J; Li, Z; Liu, X; Lu, Y; Ratliff, T1
Chen, Q; Guo, X; Jiang, Q; Jing, G; Liu, J; Wang, Y; Zhang, C; Zhang, X; Zhuo, X1
Fu, Z; Gheghiani, L; Shang, S1

Other Studies

6 other study(ies) available for nocodazole and bi 2536

ArticleYear
Formation of stable attachments between kinetochores and microtubules depends on the B56-PP2A phosphatase.
    Nature cell biology, 2011, Aug-28, Volume: 13, Issue:10

    Topics: Aurora Kinase B; Aurora Kinases; Benzamides; Cell Cycle Proteins; Chromosome Segregation; HeLa Cells; Humans; Indoles; Kinetochores; Leupeptins; Microscopy, Fluorescence; Microtubules; Nocodazole; Phosphorylation; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Quinazolines; Recombinant Fusion Proteins; RNA Interference; Sulfonamides; Time Factors; Transfection; Tumor Suppressor Proteins

2011
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer.
    Molecular cancer therapeutics, 2013, Volume: 12, Issue:9

    Topics: Antimitotic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Biomarkers; Biphenyl Compounds; Breast Neoplasms; DNA Methylation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Heterocyclic Compounds, 2-Ring; Humans; MCF-7 Cells; Neoplasm Metastasis; Nitrophenols; Nocodazole; Paclitaxel; Piperazines; Prognosis; Pteridines; Sulfonamides

2013
Stathmin and microtubules regulate mitotic entry in HeLa cells by controlling activation of both Aurora kinase A and Plk1.
    Molecular biology of the cell, 2013, Volume: 24, Issue:24

    Topics: Aurora Kinase A; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Cycle Proteins; Cell Line, Tumor; Centrosome; Cyclin B; G2 Phase Cell Cycle Checkpoints; HeLa Cells; Humans; Microtubules; Mitosis; Nocodazole; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; RNA Interference; RNA, Small Interfering; Stathmin; Tubulin; Tubulin Modulators

2013
Plk1 phosphorylation of PTEN causes a tumor-promoting metabolic state.
    Molecular and cellular biology, 2014, Oct-01, Volume: 34, Issue:19

    Topics: Animals; Antineoplastic Agents; Benzamides; Cell Cycle Proteins; Cell Line, Tumor; Cell Transformation, Neoplastic; Endosomal Sorting Complexes Required for Transport; Gene Expression Regulation; Glucose; Glycolysis; HEK293 Cells; Heterocyclic Compounds, 2-Ring; Humans; Lactic Acid; Liver; Mice; Mice, Nude; Nedd4 Ubiquitin Protein Ligases; Neoplasms, Experimental; Nocodazole; Phosphatidylinositol 3-Kinase; Phosphorylation; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; PTEN Phosphohydrolase; Pteridines; Signal Transduction; Ubiquitin-Protein Ligases

2014
Usp16 regulates kinetochore localization of Plk1 to promote proper chromosome alignment in mitosis.
    The Journal of cell biology, 2015, Aug-31, Volume: 210, Issue:5

    Topics: Cell Cycle Proteins; Cell Line, Tumor; Chromosome Segregation; Chromosomes; HEK293 Cells; HeLa Cells; Humans; Kinetochores; Microtubules; Mitosis; Nocodazole; Phosphorylation; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; RNA Interference; RNA, Small Interfering; Ubiquitin Thiolesterase; Ubiquitination

2015
Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer.
    Scientific reports, 2020, 07-23, Volume: 10, Issue:1

    Topics: Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Nucleus; Cell Survival; Drug Synergism; Forkhead Box Protein O1; Humans; Male; Molecular Targeted Therapy; Neoplasm Staging; Nocodazole; Phosphorylation; Polo-Like Kinase 1; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Signal Transduction; Transcription, Genetic

2020